Covaxx is a biotech company developing diagnostic tests and vaccines designed to cure COVID-19.
Business Model:
Revenue: $0
Employees: 11-50
Address: 1717 Main Street
City: Dallas
State: TX
Zip: 75201
Country: US
Covaxx has announced that their vaccine development efforts will be consolidated under the newly formed holding company, Vaxxinity, Inc. The company is headquartered in Dallas, Texas, and has operations in Asia, Europe, Latin America, and the United States. Vaxxinity has acquired wholly-owned subsidiaries COVAXX and United Neuroscience. Vaxxinity&s;s Board of Directors has been appointed by Lou Reese, the Executive Chairman of COVAXX. Mei Mei Hu, former CEO of COVAXX, has been named CEO of Vaxxinity.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2020 | Venture Round | $14.8M | 8/2020 | Venture Round | 1 | $18M |
Ministry of Health and Welfare (Taiwan) Ministry of Health and Welfare (Taiwan) |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|